Scheme 2 Opening of the bis-sultone 13 with FÀ or 18FÀ then with amine (a conversion rate determined by 1H NMR; b RCY calculated from
[
18F]TBAF, determined after HPLC separation, and decay corrected, mean value from 5 runs, range: Æ2%, *—SPE included).
or acidic10 conditions failed. Defluorination was observed in
all cases (data not shown). Based on the results obtained with
benzylsultone 1, we then designed the bis-sultone 13 as an
attractive labelling precursor (Scheme 2). The strategy for
biopolymer labelling starting from the bis-sultone 13 would
be the consecutive ring opening of the two sultone moieties
first with [18F]fluoride to lead to the intermediate [18F]14, then
with amine without the need for any additional reagents. In the
non-radioactive synthesis, the fluorination of the bis-sultone
13 to the fluorosulfonate 14 was performed with TBAF in
acetonitrile at rt for 24 h (94% conversion). Amination with
ethylamine and lysine chosen as model amine compounds was
achieved in an acetonitrile/water mixture at rt for 24 h to yield
the disulfonates 15 and 16 (87 and 82% conversion from 13
respectively). Radiofluorination of the bis-sultone 13 was
carried out in acetonitrile using azeotropically ‘‘dried’’
[18F]TBAF in the presence of nBu4NHCO3. The highest
RCY of [18F]fluorosulfonate 14 (67% before SPE, 50% after
SPE) was obtained at 70 1C for 5 min. Amination of the
[18F]fluorosulfonate 14 was performed in a water/acetonitrile
mixture and was nearly quantitative when achieved at 110 1C
for 15 min. According to a one-pot procedure (no SPE of
[18F]14), final disulfonates [18F]15 and [18F]16 were obtained in
60 and 55% RCYs, respectively, from [18F]TBAF. The total
synthesis of [18F]16 including SPE for both [18F]14 and [18F]16
was carried out in 36% RCY from [18F]TBAF. No traces of
the starting bis-sultone 13 were detected by HPLC analysis
(UV trace) of [18F]16.
radiofluorination approach and opened new perspectives in
targeted PET imaging using biopolymers. Further develop-
ments in both radiochemistry and radiotracer development
are underway in the laboratory.
Notes and references
1 M. E. Phelps, Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 9226;
S. M. Orkavi, Eur. J. Nucl. Med., 2001, 28, 929; M. C. Lasne,
C. Perrio, J. Rouden, L. Barre, D. Roeda, F. Dolle and C. Crouzel,
Top. Curr. Chem., 2002, 222, 201; H. H. Coenen, PET-radio-
pharmaceuticals: fluorinated compounds, Clinical Molecular
Anatomic Imaging: PET, PET/CT and SPECT/CT, Lippincott
Williams & Wilkins, 2003, ch. 16; S. M. Ametamey, M. Honer and
P. A. Schubiger, Chem. Rev., 2008, 108, 1501; L. Cai, S. Lu and
V. W. Pike, Eur. J. Org. Chem., 2008, 2853.
2 H. J. Wester and M. Schottelius, Ernst Schering Res. Found.
Workshop, 2007, 79; S. Lee, J. Xie and X. Chen, Chem. Rev.,
2010, 110, 3087; D. E. Olberg and O. K. Hjelstuen, Curr. Top.
Med. Chem., 2010, 10, 1669; B. Kuhnast and F. Dolle
Radiopharm., 2010, 3, 174.
´
, Curr.
3 R. Schirrmacher, G. Bradtmoller, E. Schirrmacher, O. Thews,
J. Tillmanns, T. Seissmeier, H. G. Buchholz, P. Bartenstein,
B. Wangler, C. M. Niemeyer and K. Jurkschat, Angew. Chem.,
Int. Ed., 2006, 45, 6047; R. Ting, C. Harwig, U. auf dem Keller,
S. McCormick, P. Austin, C. M. Overall, M. J. Adam, T. J. Ruth
and D. M. Perrin, J. Am. Chem. Soc., 2005, 127, 13094.
4 M. Glaser, M. Morrison, M. Solbakken, J. Arukwe, H. Karlsen,
U. Wiggen, S. Champion, G. M. Kindberg and A. Cuthbertson,
Bioconjugate Chem., 2008, 19, 951.
5 Z. Wu, Z. B. Li, W. Cai, L. He, F. T. Chin, F. Li and X. Chen, Eur.
J. Nucl. Med. Mol. Imaging, 2007, 34, 1823; Z. Wu, Z. B. Li,
K. Chen, W. Cai, L. He, F. T. Chin, F. Li and X. Chen, J. Nucl.
Med., 2007, 48, 1536; D. E. Olberg, A. Cuthbertson,
M. Solbakken, J. M. Arukwe, H. Qu, A. Kristian, S. Bruheim
and O. K. Hjelstuen, Bioconjugate Chem., 2010, 21, 2297.
6 J. Auernheimer, I. Dijkgraaf and H. J. Wester, in Recent Advances
of Bioconjugation Chemistry in Molecular Imaging, Carbohydration
of Radiolabeled Peptides, ed. X. Chen, 2008, p. 95.
7 For a review, see: D. W. Roberts and D. L. Williams, Tetrahedron,
1987, 43, 1027.
8 Y. Magata, L. Lang, D. O. Kiesewetter, E. M. Jagoda,
M. A. Channing and W. C. Eckelman, Nucl. Med. Biol., 2000,
27, 163.
9 G. Getvoldsen, A. Fredriksson, N. Elander and S. Stone-Elander,
J. Labelled Compd. Radiopharm., 2004, 47, 139.
10 S. F. Wnuk, S. M. Chowdhury, P. I. Garcia Jr. and M. J. Robins,
J. Org. Chem., 2002, 67, 1816.
In summary, we have developed a new efficient and clean
radiofluorination method based on the sultone opening with
[18F]fluoride. This method has led for the first time to water
soluble [18F]fluoro sulfonates which can be easily purified by
simple SPE. The methodology has been successfully extended to
a two-step sequence including radiofluorination then coupling
to lysine starting from a bis-sultone. This sequence was achieved
with high radiochemical yields without any additional reagents.
In this context, we believe that this procedure has a strong
potential to label macromolecular substrates with fluorine-18.
The overall work enlarged the scope of the nucleophilic
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 11465–11467 11467